EtravirinEtravirin
姚鹏,宫平
摘要(Abstract)：
关键词(KeyWords)：
基金项目(Foundation):
作者(Author): 姚鹏,宫平
参考文献(References)：
- [1]DE COR,DE JON,HEE,et al.Preparation of arylaminopy-ri midines as inhibitors of HI Vreplication:WO,2000/027825[P].2000-05-18.
- [2]DON W,LUD,DE COR,et al.Evolution of anti-HI V drug canditates.Part3:diarylpyri midine(DAPY)analogues[J].Bio Med Chem Lett,2001,11(17):2235-2239.
- [3]US FDA.FDAlabellinginformation[EB/OL].[2008-01-18].http://www.fda.gov/cder/foi/label/2008/022187lbl.pdf.
- [4]JOS V M,PED C,BEA G,et al.Efficacy and safety of TMC125(etravirine)intreatment-experienced HI V-1-infected patients in DUET-1:24-week results froma randomised,dou-ble-blind,placebo-controlled trial[J].The Lancet,2007,370(9581):29-38.
- [5]ADR L,THO C,BONC,et al.Efficacy and safety of TMC125(etravirine)in treatment-experienced HI V-1-infected patients in DUET-2:24-weekresults froma randomised,double-blind,placebo-controlled trial[J].The Lancet,2007,370(9581):39-48.